Journal issues > Issue 1, January 2025 > A concise and non-exhaustive overview of neurological complications in patients treated for solid tumours

A concise and non-exhaustive overview of neurological complications in patients treated for solid tumours

By: L. Seynaeve MD

SUMMARY

Neurological diseases occur more frequently in patients with active tumours and/or undergoing treatment for oncological disease. Malignancy-associated changes in cell signalling and biological processes occur, as well as “naturally occurring” and treatment-induced immune-related adverse events that can be both cell- or antibody-mediated. Prompt evaluation, timely accurate treatment, and interdisciplinary care are of paramount importance to prevent or diminish long-term neurological sequelae and mortality.

(BELG J MED ONCOL 2025;19(1):11–14)

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top